Copyright © 2006 by Mosby, Inc. Slide 1 PART III Infectious Pulmonary Diseases.

40
Copyright © 2006 by Mosby, Inc. Slide 1 PART III PART III Infectious Pulmonary Diseases Infectious Pulmonary Diseases

Transcript of Copyright © 2006 by Mosby, Inc. Slide 1 PART III Infectious Pulmonary Diseases.

Copyright © 2006 by Mosby, Inc.Slide 1

PART IIIPART III

Infectious Pulmonary DiseasesInfectious Pulmonary Diseases

Copyright © 2006 by Mosby, Inc.Slide 2

Chapter 15

Figure 15-1. Cross-sectional view of alveolar consolidation in pneumonia. Figure 15-1. Cross-sectional view of alveolar consolidation in pneumonia. TI,TI, Type I cell; Type I cell;TII,TII, type II cell; type II cell; M,M, macrophage; macrophage; AC,AC, alveolar consolidation; alveolar consolidation; L,L, leukocyte; leukocyte; RBC,RBC, red blood cell. red blood cell.

Chapter 15Chapter 15PneumoniaPneumonia

Copyright © 2006 by Mosby, Inc.Slide 3

Anatomic Alterations of the LungsAnatomic Alterations of the Lungs

Inflammation of the alveoliInflammation of the alveoli

Alveolar consolidationAlveolar consolidation

AtelectasisAtelectasis

Copyright © 2006 by Mosby, Inc.Slide 4

EtiologyEtiology

Bacterial CausesBacterial Causes

Gram-positive organismsGram-positive organisms StreptococcusStreptococcus

StaphylococcusStaphylococcus

Copyright © 2006 by Mosby, Inc.Slide 5

Figure 15-2. Figure 15-2. The The StreptococcusStreptococcus organism is a gram-positive, nonmotile coccus organism is a gram-positive, nonmotile coccus that is found singly, in pairs, and in short chains.that is found singly, in pairs, and in short chains.

Copyright © 2006 by Mosby, Inc.Slide 6

Figure 15-3. Figure 15-3. The The StaphylococcusStaphylococcus organism is a gram-positive, nonmotile coccus organism is a gram-positive, nonmotile coccus that is found singly, in pairs, and in irregular clusters.that is found singly, in pairs, and in irregular clusters.

Copyright © 2006 by Mosby, Inc.Slide 7

EtiologyEtiology

Gram-negative organismsGram-negative organisms

Haemophilus influenzaeHaemophilus influenzae

KlebsiellaKlebsiella

Pseudomonas aeruginosaPseudomonas aeruginosa

Moraxella catarrhalis Moraxella catarrhalis

Escherichia coliEscherichia coli

Serratia Serratia speciesspecies

Enterobacter Enterobacter speciesspecies

Copyright © 2006 by Mosby, Inc.Slide 8

Figure 15-4. Figure 15-4. The bacilli are rod-shaped microorganisms and are the major The bacilli are rod-shaped microorganisms and are the major gram-negative organisms responsible for pneumonia.gram-negative organisms responsible for pneumonia.

Copyright © 2006 by Mosby, Inc.Slide 9

EtiologyEtiology

Atypical organismsAtypical organisms

Mycoplasma pneumoniaeMycoplasma pneumoniae

Legionella pneumophilaLegionella pneumophila

Chlamydia psittaciChlamydia psittaci

Chlamydia pneumoniaeChlamydia pneumoniae

Copyright © 2006 by Mosby, Inc.Slide 10

EtiologyEtiology

Anaerobic bacterial infectionsAnaerobic bacterial infections

Peptostreptococcus Peptostreptococcus speciesspecies

Bacteroides melaninogenicusBacteroides melaninogenicus

Fusobacterium necrophorumFusobacterium necrophorum

Bacteroides asaccharolyticusBacteroides asaccharolyticus

Porphyromonas endodontalisPorphyromonas endodontalis

Porphyromonas gingivalisPorphyromonas gingivalis

Copyright © 2006 by Mosby, Inc.Slide 11

EtiologyEtiology

Viral causesViral causes

InfluenzavirusInfluenzavirus

Respiratory syncytial virusRespiratory syncytial virus

Parainfluenza virusParainfluenza virus

AdenovirusAdenovirus

Coronavirus (SARS)Coronavirus (SARS)

Copyright © 2006 by Mosby, Inc.Slide 12

EtiologyEtiology

Other causesOther causes Rickettsial infectionsRickettsial infections VaricellaVaricella RubellaRubella Aspiration pneumonitisAspiration pneumonitis Lipoid pneumonitisLipoid pneumonitis Pneumocystis cariniiPneumocystis carinii CytomegalovirusCytomegalovirus TuberculosisTuberculosis Fungal infectionsFungal infections

Copyright © 2006 by Mosby, Inc.Slide 13

EtiologyEtiology

Acquired pneumonia classificationAcquired pneumonia classification

Community-acquired pneumonia (CAP)Community-acquired pneumonia (CAP)

Nursing home–acquired pneumoniaNursing home–acquired pneumonia

Hospital-acquired pneumoniaHospital-acquired pneumonia

Ventilator-associated pneumoniaVentilator-associated pneumonia

Copyright © 2006 by Mosby, Inc.Slide 14

Overview of the Cardiopulmonary Overview of the Cardiopulmonary Clinical Manifestations Associated Clinical Manifestations Associated

with PNEUMONIAwith PNEUMONIA

The following clinical manifestations result from the The following clinical manifestations result from the pathophysiologic mechanisms caused (or activated) pathophysiologic mechanisms caused (or activated) by by Alveolar Consolidation Alveolar Consolidation (see Figure 9-8),(see Figure 9-8), Increased Alveolar-Capillary Membrane Increased Alveolar-Capillary Membrane ThicknessThickness (see Figure 9-9), and (see Figure 9-9), and AtelectasisAtelectasis (see (see Figure 9-7)—the major anatomic alterations of the Figure 9-7)—the major anatomic alterations of the lungs associated with pneumonia (see Figure 15-1). lungs associated with pneumonia (see Figure 15-1). During the resolution stage of pneumonia, During the resolution stage of pneumonia, Excessive Bronchial SecretionsExcessive Bronchial Secretions (see Figure 9-11) (see Figure 9-11) also may play a part in the clinical presentation.also may play a part in the clinical presentation.

Copyright © 2006 by Mosby, Inc.Slide 15

Figure 9-8. Alveolar consolidation clinical scenario.

Copyright © 2006 by Mosby, Inc.Slide 16

Figure 9-9. Increased alveolar-capillary membrane thickness clinical scenario.

Copyright © 2006 by Mosby, Inc.Slide 17

Figure 9-7. Atelectasis clinical scenario.

  

Copyright © 2006 by Mosby, Inc.Slide 18

Figure 9-11. Excessive bronchial secretions clinical scenario.

  

Copyright © 2006 by Mosby, Inc.Slide 19

Clinical Data Obtained at the Clinical Data Obtained at the Patient’s BedsidePatient’s Bedside

Vital signsVital signs

Increased respiratory rateIncreased respiratory rate

Increased heart rate, cardiac output, Increased heart rate, cardiac output, blood pressureblood pressure

Copyright © 2006 by Mosby, Inc.Slide 20

Clinical Data Obtained at theClinical Data Obtained at the Patient’s Bedside Patient’s Bedside

Chest pain/decreased chest expansionChest pain/decreased chest expansion

CyanosisCyanosis

Cough, sputum production, and hemoptysisCough, sputum production, and hemoptysis

Chest assessment findingsChest assessment findings Increased tactile and vocal fremitusIncreased tactile and vocal fremitus Dull percussion noteDull percussion note Bronchial breath soundsBronchial breath sounds Crackles and rhonchiCrackles and rhonchi Pleural friction rub Pleural friction rub Whispered pectoriloquyWhispered pectoriloquy

Copyright © 2006 by Mosby, Inc.Slide 21

Figure 2-11. Figure 2-11. A short, dull, or flat percussion note is typically produced over areas A short, dull, or flat percussion note is typically produced over areas of alveolar consolidation.of alveolar consolidation.

Copyright © 2006 by Mosby, Inc.Slide 22

Figure 2-16. Figure 2-16. Auscultation of bronchial breath sounds over a consolidated lung Auscultation of bronchial breath sounds over a consolidated lung unit.unit.

Copyright © 2006 by Mosby, Inc.Slide 23

Figure 2-19. Figure 2-19. Whispered voice sounds auscultated over a normal lungWhispered voice sounds auscultated over a normal lungare usually faint and unintelligible.are usually faint and unintelligible.

Copyright © 2006 by Mosby, Inc.Slide 24

Clinical Data Obtained from Clinical Data Obtained from Laboratory Tests and Special Laboratory Tests and Special

ProceduresProcedures

Copyright © 2006 by Mosby, Inc.Slide 25

Pulmonary Function Study: Pulmonary Function Study: Expiratory Maneuver FindingsExpiratory Maneuver Findings

FVC FEVFVC FEVTT FEF FEF25%-75%25%-75% FEF FEF200-1200200-1200

N or N or N or N or N N

PEFRPEFR MVV FEFMVV FEF50% 50% FEVFEV1%1%

N N or N N or N N or N N or

FVC FEVFVC FEVTT FEF FEF25%-75%25%-75% FEF FEF200-1200200-1200

N or N or N or N or N N

PEFRPEFR MVV FEFMVV FEF50% 50% FEVFEV1%1%

N N or N N or N N or N N or

Copyright © 2006 by Mosby, Inc.Slide 26

Pulmonary Function Study Pulmonary Function Study Lung Volume and Capacity Findings Lung Volume and Capacity Findings

VT RV FRC TLC

N or

VC IC ERV RV/TLC%

N

VT RV FRC TLC

N or

VC IC ERV RV/TLC%

N

Copyright © 2006 by Mosby, Inc.Slide 27

Arterial Blood GasesArterial Blood Gases

Mild to Moderate PneumoniaMild to Moderate Pneumonia

Acute alveolar hyperventilation with Acute alveolar hyperventilation with hypoxemiahypoxemia

pH PaCO2 HCO3- PaO2

(Slightly)

Copyright © 2006 by Mosby, Inc.Slide 28

Time and Progression of Disease Time and Progression of Disease

100100

5050

3030

8080

00

PaCO2

1010

2020

4040

Alveolar HyperventilationAlveolar Hyperventilation

6060

7070

9090 Point at which PaO2 declines enough to stimulate peripheral oxygen receptors

Point at which PaO2 declines enough to stimulate peripheral oxygen receptors

PaO2

Disease OnsetDisease OnsetP

aO2

or

PaC

O2

PaO

2 o

r P

aCO

2

Figure 4-2. PaO2 and PaCO2 trends during acute alveolar hyperventilation.

Copyright © 2006 by Mosby, Inc.Slide 29

Arterial Blood GasesArterial Blood Gases

Severe PneumoniaSevere Pneumonia

Acute ventilatory failure with hypoxemiaAcute ventilatory failure with hypoxemia

pH PaCO2 HCO3- PaO2

(Slightly)

Copyright © 2006 by Mosby, Inc.Slide 30

Time and Progression of DiseaseTime and Progression of Disease

100100

5050

3030

80

0

PaO2

1010

2020

4040

Alveolar HyperventilationAlveolar Hyperventilation

6060

7070

9090Point at which PaO2 declines enough to stimulate peripheral oxygen receptors

Point at which PaO2 declines enough to stimulate peripheral oxygen receptors

PaCO 2

Acute Ventilatory Failure Acute Ventilatory FailureDisease OnsetDisease Onset

Point at which disease becomes severe and patient begins to become fatigued

Point at which disease becomes severe and patient begins to become fatigued

Pa0

2 o

r P

aC0 2

Pa0

2 o

r P

aC0 2

Figure 4-7. PaO2 and PaCO2 trends during acute ventilatory failure.

Copyright © 2006 by Mosby, Inc.Slide 31

Oxygenation IndicesOxygenation Indices

QS/QTDO2 VO2 C(a-v)O2

Normal Normal

O2ER SvO2

QS/QTDO2 VO2 C(a-v)O2

Normal Normal

O2ER SvO2

Copyright © 2006 by Mosby, Inc.Slide 32

Time and Progression of DiseaseTime and Progression of Disease

100100

5050

3030

80

0

PaO2

1010

2020

4040

Alveolar HyperventilationAlveolar Hyperventilation

6060

7070

9090Point at which PaO2 declines enough to stimulate peripheral oxygen receptors

Point at which PaO2 declines enough to stimulate peripheral oxygen receptors

PaCO 2

Acute Ventilatory Failure Acute Ventilatory FailureDisease OnsetDisease Onset

Point at which disease becomes severe and patient begins to become fatigued

Point at which disease becomes severe and patient begins to become fatigued

Pa0

2 o

r P

aC0 2

Pa0

2 o

r P

aC0 2

Figure 4-7. PaO2 and PaCO2 trends during acute or Acute ventilatory failure.

Copyright © 2006 by Mosby, Inc.Slide 33

Abnormal Laboratory Tests and Abnormal Laboratory Tests and ProceduresProcedures

Sputum examinationSputum examination

Gram-positive organismsGram-positive organisms StreptococcusStreptococcus

StaphylococcusStaphylococcus

Gram-negative organismsGram-negative organisms KlebsiellaKlebsiella

Pseudomonas aeruginosaPseudomonas aeruginosa

Haemophilus influenzaeHaemophilus influenzae

Legionella pneumophilaLegionella pneumophila

Copyright © 2006 by Mosby, Inc.Slide 34

Radiologic FindingsRadiologic Findings

Chest radiographChest radiograph

Increased density Increased density

Air bronchogramsAir bronchograms

Pleural effusionsPleural effusions

CT scanCT scan

Consolidation and bronchograms Consolidation and bronchograms may be seenmay be seen

Copyright © 2006 by Mosby, Inc.Slide 35

Figure 15-5. Chest X-ray film of a 20-year-old woman with severe pneumonia of the left lung.

Copyright © 2006 by Mosby, Inc.Slide 36

Figure 15-6. Air bronchogram. The branching linear lucencies within the consolidation in the right lower lobe are particularly well demonstrated in this example of staphylococcal pneumonia. (From

Armstrong P et al: Imaging of diseases of the chest, ed 2, St. Louis, 1995, Mosby.)

Copyright © 2006 by Mosby, Inc.Slide 37

Figure 15-7. Air bronchogram shown by CT in a patient with pneumonia. (From Armstrong P et al: Imaging of diseases of the chest, ed 2, St. Louis, 1995, Mosby.)

Copyright © 2006 by Mosby, Inc.Slide 38

General Management of General Management of PneumoniaPneumonia

Respiratory care treatment protocolsRespiratory care treatment protocols

Oxygen therapy protocolOxygen therapy protocol

Bronchopulmonary hygiene therapy protocolBronchopulmonary hygiene therapy protocol

Copyright © 2006 by Mosby, Inc.Slide 39

General Management of General Management of PneumoniaPneumonia

Medications and procedures commonlyMedications and procedures commonlyprescribed by the physicianprescribed by the physician

AntibioticsAntibiotics

Analgesic agentsAnalgesic agents

Ribavirin aerosolRibavirin aerosol

Aerosolized pentamidineAerosolized pentamidine

ThoracentesisThoracentesis

Copyright © 2006 by Mosby, Inc.Slide 40

Classroom DiscussionClassroom DiscussionCase Study: PneumoniaCase Study: Pneumonia